Evidence map›Paper›PMID 42459434›Full record

ArticleIranian journal of parasitology

A Therapeutic Side Effect on Hydatid Cyst after Lung Cancer Treatment: A Case Report.

Cebrail Akyuz, Kadir Çorbaci

Abstract readCase Reports
In one paragraph

Article in Iranian journal of parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Cebrail AkyuzDepartment of General Surgery, University of Health Sciences, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
Kadir ÇorbaciDepartment of General Surgery, Bilecik Şeyh Edebali University, Faculty of Medicine, Bilecik, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic echinococcus (CE) is an important health problem affecting societies living especially in rural areas. Our patient was a 64-year-old male who received PAIR treatment and albendazole treatment for CE at Haydarpaşa Numune Training and Research Hospital, Istanbul, Turkey between 2022 and 2025. The patient was first operated on for lung cancer. After treatment, the patient continues to live asymptomatically in the 36-month follow-up. We observed and followed up that the paxlitaxel and carboplatin treatments received by our patient caused regression in the CE lesions. We think that the effectiveness of this situation should be evaluated first with experimental studies.

Indexed as

ChemotherapyCystic echinococcusPositive side effectTreatment

Identifiers

PMID42459434
PMCPMC13369442

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.